| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.8K | $3.82M | - | |
| Other | 133.1K | $3.44M | - | |
| CEO | 132.7K | $3.43M | - | |
| CFO | 105.7K | $2.73M | - | |
| VP | 95.7K | $2.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2020 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 12,798 | $74.19 | $949,431.46 | -5.9% | |
| Jun 3, 2020 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 2,516 | $74.69 | $187,920.04 | -10.8% | |
| May 26, 2020 | Huizenga Theodore Alan65 | SVP, Controller And Pao | Sell | 260 | $74.93 | $19,481.80 | -1.4% | |
| May 19, 2020 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 29,113 | $73.33 | $2,134,885.26 | -6.7% | |
| May 18, 2020 | Aliski William | Director | Sell | 20,000 | $74.02 | $1,480,322.00 | -22.1% | |
| May 18, 2020 | Aliski William | Director | Sale+OE | 7,500 | $74.65 | $559,875.00 | -13.5% | |
| May 18, 2020 | Fust Matthew K77 | Director | Sell | 1,875 | $75.00 | $140,625.00 | -14.6% | |
| May 18, 2020 | Parschauer Karah Herdman77 | EVP And General Counsel | Sell | 2,722 | $74.72 | $203,374.23 | -9.1% | |
| May 15, 2020 | Huizenga Theodore Alan65 | SVP, Controller And Pao | Sale+OE | 2,461 | $71.00 | $174,731.00 | -6.1% | |
| Apr 22, 2020 | Fust Matthew K77 | Director | Sell | 1,875 | $65.00 | $121,875.00 | -12.7% |